Winfred
Back to Startups
Congenica

Congenica

Congenica provides software that accelerates genomic data analysis for personalised medicine.

London, UK— Website
£91.3MTotal raised

Congenica develops genomic analysis software for interpreting complex data related to rare diseases and inherited cancer. The company serves a global customer base of hospitals, laboratories, and pharmaceutical companies across multiple continents.

Categories

BioTech

Team

David Atkins

David Atkins

Chief Executive Officer

David brings healthcare leadership experience, having served as chief executive officer at Congenica and Rhythm Biosciences Limited, alongside advisory and board roles across the sector.

LinkedIn
AR

Andy Richards

Chairman

NK

Noah Konig

Head of Marketing

Noah brings marketing and communications experience from roles at PrecisionLife, Congenica, and Cambridge Cognition. He previously worked as a strategic communications consultant at Barclays.

LinkedIn

Investors

  1. Series C
    £39.0M
    Legal & General
    Legal & General    LeadFollow-on
    Tencent
    Tencent    LeadFollow-on
    Parkwalk
    Parkwalk    Follow-on
    Cambridge Innovation Capital
    Cambridge Innovation Capital    Follow-on
    D
    Downing    Follow-on
    X
    Xeraya    Follow-on
    PC
    Puhua Capital    Follow-on
    II
    IDO Investments    Follow-on
    QVentures
    QVentures
  2. Series C
    £39.0M
    Tencent
    Tencent    Lead
    Legal & General
    Legal & General    Lead
    X
    Xeraya
    PC
    Puhua Capital
    II
    IDO Investments
    Parkwalk
    Parkwalk
    Cambridge Innovation Capital
    Cambridge Innovation Capital
    D
    Downing
  3. Series B
    £13.3M
    Parkwalk Advisors
    Parkwalk Advisors    Lead
    DC
    Digital China Health Technologies Corporation

Funding history